Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma.

SJ O'Day; AMM Eggermont; V Chiarion-Sileni; R Kefford; JJ Grob; L Mortier; C Robert; J Schachter; A Testori; J Mackiewicz; P Friedlander; C Garbe; Selma Ugurel-Becker; F Collichio; W Guo; J Lufkin; S Bahcall; V Vukovic; A Hauschild

doi:10.1200/JCO.2012.44.5585

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma.

SJ O'Day
, AMM Eggermont
, V Chiarion-Sileni
, R Kefford
, JJ Grob
, L Mortier
, C Robert
, J Schachter
, A Testori
, J Mackiewicz
, P Friedlander
, C Garbe
, Selma Ugurel-Becker
, F Collichio
, W Guo
, J Lufkin
, S Bahcall
, V Vukovic
, A Hauschild

Universitätsklinik für Dermatologie und Venerologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

296 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Journal of Clinical Oncology
DOIs	https://doi.org/10.1200/JCO.2012.44.5585
Publikationsstatus	Veröffentlicht - 2013

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin

Forschungsfelder

Krebsforschung

Zugriff auf Dokument

10.1200/JCO.2012.44.5585

Andere Dateien und Links

Dieses zitieren

O'Day, SJ., Eggermont, AMM., Chiarion-Sileni, V., Kefford, R., Grob, JJ., Mortier, L., Robert, C., Schachter, J., Testori, A., Mackiewicz, J., Friedlander, P., Garbe, C., Ugurel-Becker, S., Collichio, F., Guo, W., Lufkin, J., Bahcall, S., Vukovic, V., & Hauschild, A. (2013). Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2012.44.5585

@article{77b952fc28ae4eedb7a17185bb664ab7,

title = "Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma.",

author = "SJ O'Day and AMM Eggermont and V Chiarion-Sileni and R Kefford and JJ Grob and L Mortier and C Robert and J Schachter and A Testori and J Mackiewicz and P Friedlander and C Garbe and Selma Ugurel-Becker and F Collichio and W Guo and J Lufkin and S Bahcall and V Vukovic and A Hauschild",

year = "2013",

doi = "10.1200/JCO.2012.44.5585",

language = "English",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

}

O'Day, SJ, Eggermont, AMM, Chiarion-Sileni, V, Kefford, R, Grob, JJ, Mortier, L, Robert, C, Schachter, J, Testori, A, Mackiewicz, J, Friedlander, P, Garbe, C, Ugurel-Becker, S, Collichio, F, Guo, W, Lufkin, J, Bahcall, S, Vukovic, V & Hauschild, A 2013, 'Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma.', Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2012.44.5585

TY - JOUR

T1 - Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma.

AU - O'Day, SJ

AU - Eggermont, AMM

AU - Chiarion-Sileni, V

AU - Kefford, R

AU - Grob, JJ

AU - Mortier, L

AU - Robert, C

AU - Schachter, J

AU - Testori, A

AU - Mackiewicz, J

AU - Friedlander, P

AU - Garbe, C

AU - Ugurel-Becker, Selma

AU - Collichio, F

AU - Guo, W

AU - Lufkin, J

AU - Bahcall, S

AU - Vukovic, V

AU - Hauschild, A

PY - 2013

Y1 - 2013

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000316187600022

UR - https://pubmed.ncbi.nlm.nih.gov/23401447

U2 - 10.1200/JCO.2012.44.5585

DO - 10.1200/JCO.2012.44.5585

M3 - Research article

C2 - 23401447

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -